OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
October 01, 2011
Thirty Years of Pharm Exec
Y.K. Hamied, PhD, Chairman, Cipla
Fred Frank, Vice Chairman, P.J. Solomon Co.
Marck McClellan, MD, Director, Engelberg Center for Health Reform, Brookings Institute
Pharm Exec sits down with Steve Collis, CEO of AmerisourceBergen to discuss his agenda for retooling the drug distribution giant.
Daniel Vasella, MD, Chairman, Novartis
Angus Russell, CEO, Shire
Atsushi Nagahisa, President & CEO, RaQualia
Jean-Claude Labrune, Chairman & CEO, Cegedim Group
Henry Waxman, Congressional Representative from Los Angeles, California
Harvey Bale, Jr., MD, former Director-General, IFPMA
Top 10 Companies by Market Share
Dennis Gillings, Chairman & CEO, Quintils Transnational Corp.
Robert Seidman, Former Chief Pharmacy Officer, Wellpoint
Jane Henney, MD, Former FDA Commissioner
P. Roy Vagelos, MD, Chairman Emeritus, Merck
Success in the emerging markets depends significantly on navigating the myths and mental traps.
The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.
Pharm Exec celebrates its 30th birthday with a gathering of 30 of the industry's key influencers of the last three decades.
Francis Collins, MD, PhD, Director, National Institutes of Health
Abbey Meyers, Founder, National Organization of Rare Disorders
Napoleone Ferrara, MD, PhD, Research Fellow, Genentech
Martin Wygod, Chairman, WebMD
Candan Karabagli, CEO, Abdi Ibrahim A.S.
Sidney Wolfe, MD, Director, Public Citizen's Health Research Group
30 Years of Pharma: Perspective in Numbers
Janet Woodcock, MD, Director, FDA Center for Drug Evaluation and Research
Sir Michael Rawlins, Chairman of the UK National Institute for Health and Clinical Excellence
Top 10 Products Worldwide
Josef von Rickenbach, President & CEO, Parexel